Why the same molecule appears under two names in the literature

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
LY3437943 is the sponsor's internal development code for the molecule later given the international nonproprietary name retatrutide. The 2022 discovery paper and the phase 1b trial use the code; the phase 2 publications use the name. A literature search that uses only one will miss the other.

Development codes

A pharmaceutical sponsor assigns an alphanumeric code to a compound when it enters development, before it has a name. The prefix identifies the company and the digits the compound. The code persists in early publications, trial registrations and patents.

It remains the most precise identifier, because it points to exactly one molecule from one programme.

The nonproprietary name

An international nonproprietary name is assigned through a World Health Organization process once a compound progresses. The suffix follows conventions that group related molecules — the "-tide" ending marks a peptide, and the stem indicates the class.

Retatrutide was assigned during the compound's clinical development, which is why the earlier papers predate it.

Why this matters when reading

Searching only "retatrutide" misses the discovery paper and the phase 1b trial, which are the sources for the molecule's design and pharmacokinetics. Searching only the code misses everything from phase 2 onward.

Both names refer to the same molecule, and a supplier's documentation may use either. Identity is confirmed by mass spectrometry, not by which name is printed.

Supply

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

Development codes?

A pharmaceutical sponsor assigns an alphanumeric code to a compound when it enters development, before it has a name. The prefix identifies the company and the digits the compound. The code persists in early publications, trial registrations and patents.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.